Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...
News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the ...
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...
The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of ...
Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.
The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress toward other administration priorities in the 2026 fiscal year.
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...
The redesign is intended to streamline what was a sprawling and fractured information ecosystem, requiring users to ...
Health care companies dominate the MAHA Summit, and a look at Trump's watered down effort to lower Medicare drug prices.
Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.
Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results